PHASE 3 FRACTURE TRIAL OF ODANACATIB FOR OSTEOPOROSIS - BASELINE CHARACTERISTICS AND STUDY DESIGN

Author(s):
Papapoulos, S.; Bone, H.; Dempster, D.; Eisman, J.; Greenspan, S.; Mcclung, M.; Nakamura, T.; Shih, J.; Leung, A.; Santora, A.; Verbruggen, N.; Lombardi, A.
Published
2013
Publication type
Article / Letter to editor
Date issued
2013-04-30
Language
English
Is part of
Osteoporosis International (2013), Vol. 24, p. S151-S151
hdl
1887/100452